Why it matters: GLP-1 drugs are being studied across a wide range of health conditions after gaining FDA approval to treat type 2 diabetes, obesity, cardiovascular disease risk, liver disease, and sleep apnea
These indicate that AEP can not only improve the content of antioxidant enzymes, but also improve mitochondrial function and oxidation-related pathways to relieve diabetic
Additionally, older adults may have chronic conditions or take medications that further impact nutrient absorption and utilization
In some embodiments, the otic formulation or composition comprises about 11% by weight of the cholesterol
However, some common side effects may include nausea, diarrhea, or constipation, which usually subside as the body adjusts to the treatment